# Stability of Biometry in Meibomian Gland Dysfunction

> **NCT04322656** · NA · UNKNOWN · sponsor: **Vienna Institute for Research in Ocular Surgery** · enrollment: 31 (estimated)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** Lipiflow treatment

## Key facts

- **NCT ID:** NCT04322656
- **Lead sponsor:** Vienna Institute for Research in Ocular Surgery
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-06
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322656, "Stability of Biometry in Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04322656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*